Showing results (611-620 of 935) with videos related to
Sort By:
Pageof 94
Chest|June 11, 2003
Severe gastroesophageal reflux is associated with reduced carbon monoxide diffusing capacityLinda M Schachter, John Dixon, Robert J Pierce, et al.British Journal of Cancer|December 1, 1993
Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitorsJ Gillespie, J F Dye, M Schachter, et al.Cardiovascular Research|January 1, 1995
Role of polyamines in hypertension induced by angiotensin IIJ Ibrahim, M Schachter, A D Hughes, et al.Neuropsychologia|January 1, 1989
The performance on learning tasks of patients in the early stages of Parkinson's diseaseA G Canavan, R E Passingham, C D Marsden, et al.Human Molecular Genetics|March 1, 1996
Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneityO Bandmann, T G Nygaard, R Surtees, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1986
Familial dystonia and visual failure with striatal CT lucenciesC D Marsden, A E Lang, N P Quinn, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.European Neurology|January 1, 1987
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.Journal of Neurochemistry|March 1, 1990
Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.British Journal of Clinical Pharmacology|March 29, 2012
The absorption and metabolism of a standard oral dose of levodopa in patients with ParkinsonismS Bergmann, G Curzon, J Friedel, et al.Pageof 94